Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Vaxcyte, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- +19 vs. Q1 2022
- Shares held
- 51.4M
- +1.58M (+3.2%) vs. Q1 2022
- Total value
- $1.12B
- −$84.6M (−7.0%) vs. Q1 2022
- New holders
- 24
- 47 more added
- Sold out
- 5
- 20 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 331 | $9.71B |
| Q1 2026 | 336 | $9.44B |
| Q4 2025 | 295 | $6.81B |
| Q3 2025 | 285 | $5.09B |
| Q2 2025 | 294 | $4.80B |
| Q1 2025 | 315 | $5.88B |
| Q4 2024 | 323 | $11.5B |
| Q3 2024 | 329 | $15.6B |
| Q2 2024 | 265 | $9.26B |
| Q1 2024 | 251 | $8.13B |
| Q4 2023 | 223 | $6.47B |
| Q3 2023 | 202 | $5.17B |
| Q2 2023 | 197 | $5.00B |
| Q1 2023 | 188 | $3.15B |
| Q4 2022 | 198 | $3.91B |
| Q3 2022 | 126 | $1.36B |
| Q2 2022 | 106 | $1.12B |
| Q1 2022 | 88 | $1.20B |
| Q4 2021 | 87 | $1.06B |
| Q3 2021 | 78 | $1.10B |
| Q2 2021 | 75 | $972.7M |
| Q1 2021 | 74 | $869.2M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Vaxcyte, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 306 | $6.00K | 0.00% | +306 | New |
| Daiwa Securities Group Inc. | 179 | $4.00K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 106 | $2.00K | 0.00% | +106 | New |
| Signaturefd, LLC | 59 | $1.00K | 0.00% | +59 | New |
| Lindbrook Capital, LLC | 11 | $0 | 0.00% | −58−84.1% | Reduced |
| Covestor Ltd | 10 | $0 | 0.00% | −3−23.1% | Reduced |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −1,304,741−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −11,019−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −9,677−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −5,100−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −132−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |